$298,000
$330,000
a year
... Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of ... geographic atrophy, we are rigorously advancing our mid-to late-stage ... -making. Preferred: An MBA or advanced degree is strongly preferred. Salary ...
a day ago
$200,000
$375,000
a year
... a comprehensive range of treatments using advanced equipment such as OPG/Ceph ...
10 days ago
$228,000
$255,000
a year
... Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of ... geographic atrophy, we are rigorously advancing our mid-to late-stage ...
a day ago